Welcome to our dedicated page for Lftd Partners news (Ticker: LIFD), a resource for investors and traders seeking the latest updates and insights on Lftd Partners stock.
LFTD Partners Inc. (OTCQB: LIFD) is a publicly traded parent company based in Jacksonville, Florida, best known as the corporate parent of Lifted Made, a manufacturer and seller of Urb hemp-derived and other psychoactive products, Mielos hemp-free wellness gummies, and Rebel hemp-free energy gummies. The news surrounding LFTD Partners often centers on financial performance, product developments, collaborations, and regulatory developments affecting its hemp-derived and cannabis-related activities.
Company news releases regularly cover quarterly financial results, where LFTD Partners reports revenue, operating income or loss, net income or loss, and key balance sheet metrics. These announcements are typically accompanied by details on scheduled earnings conference calls and webcasts, giving investors and observers structured opportunities to hear management discuss the business.
Another major theme in LIFD news is brand and product initiatives at Lifted Made. Examples include the launch of Urb's "Fly High" brand identity and the Urb Miles loyalty program, as well as collaborations such as Urb NM in New Mexico, which has been recognized as a fast-growing marijuana brand. News items also highlight exclusive manufacturing arrangements for Diamond Supply Co. and Cali Sweets hemp-derived products, and manufacturing for a subsidiary of a large, publicly traded U.S. marijuana company.
Regulatory and strategic developments are also prominent. LFTD Partners has issued detailed commentary on federal legislation that could ban intoxicating hemp-derived consumable products, outlining potential impacts on sales, goodwill, investments, and inventory. Additionally, the company has announced letters of intent to acquire Illinois cannabis licenses, industrial properties, and related businesses as part of a planned expansion into the Illinois marijuana market, subject to extensive conditions and approvals.
For readers following LIFD, this news page brings together updates on earnings, legislative and regulatory developments, brand launches, collaborations, and proposed acquisitions that shape LFTD Partners' evolving position in hemp-derived products, wellness gummies, energy gummies, and cannabis-related markets.
LFTD Partners Inc. (OTCQB: LIFD) has announced its subsidiary, Lifted Made, is expanding operations with a new lease of 6,132 square feet in Kenosha, WI, effective July 1, 2022. This expansion marks the fifth in two years, increasing total space by 25% to 30,370 square feet. The lease includes a base charge of $10.75 per square foot, with a 2.5% annual rent increase. The move aims to internalize packing functions and enhance control over operations, which is expected to boost earnings per share.
LFTD Partners (OTCQB:LIFD) reported record financial results for Q1 2022, showing significant growth compared to both the previous quarter and the same quarter last year. Revenue surged 41% from Q4 2021 to $18,088,877, while net income jumped 118% to $2,944,793. On a year-over-year basis, revenue increased 439%, and net income rose 376%. Lifted Made's product sales heavily favored hemp-derived products, contributing to 96% of total sales. The company is actively pursuing $10-$15 million in debt financing to support continued growth and inventory needs.
LFTD Partners Inc. (LIFD) announced that its subsidiary, Lifted Made, is running a second shift to meet rising demand for its cannabinoid and psychedelics products. The company has expanded from 3,300 sq. ft. to 24,238 sq. ft. in Kenosha, Wisconsin, increasing its workforce from 10 to over 125 employees. Projected revenues for 2022 are anticipated to exceed $75 million, reflecting significant growth. The ongoing expansion and revenue generation highlight Lifted Made's success in the cannabis and psychedelics market.
LFTD Partners Inc. (OTCQB: LIFD), a rapidly growing cannabis and psychedelics company, will present at the Benzinga Psychedelics Capital Conference on April 19, 2022, at 2:40 PM ET in Miami Beach. The presentation will be live-streamed and recorded. LFTD's subsidiary, Lifted Made, recently launched two new psychedelic products and will discuss a new federally-compliant product expected later this year. Additionally, LFTD will sponsor the conference reception and have a booth at the Benzinga Cannabis Capital Conference from April 20-21, 2022.
LFTD Partners Inc. (OTCQB: LIFD), a rapidly growing and profitable cannabis and psychedelics company, announced that its Vice Chairman and COO Nick Warrender, along with President and CFO Jake Jacobs, were interviewed by Proactive Investors on April 4, 2022. The interview highlights their recent business developments and growth strategies. LFTD focuses on acquiring profitable companies that sell hemp-derived cannabinoid products and emerging psychedelics. The company operates through its subsidiary, Lifted Made, known for award-winning products in the market.
LFTD Partners Inc. (OTCQB:LIFD) reported exceptional financial results for Q4 and the full year of 2021, achieving a remarkable 492% revenue increase to $31.66 million compared to 2020. The company transitioned from a net loss of $(1.53 million) in 2020 to a net income of $5.80 million in 2021. Key highlights include basic earnings per share rising to $0.50. Despite a one-time impairment affecting Q4 results, LFTD expects revenues to surpass $75 million in 2022, driven by strong Q1 sales and new product launches.
LFTD Partners Inc. has officially changed its ticker symbol on the OTCQB Venture Market from LSFP to LIFD as of March 15, 2022. The company is focused on acquiring profitable businesses in the hemp-derived cannabinoid and emerging psychedelic sectors. Its first subsidiary, Lifted Made, offers award-winning hemp products, while LFTD also holds a 4.99% stake in CBD beverage company Ablis and operates distillers like Bendistillery. For further details, stakeholders are encouraged to consult SEC filings and their official websites.